KYORIN Pharmaceutical Co.,Ltd.'s total assets for Q1 2025 were ¥190.57B, a decrease of -1.57% from the previous quarter. JP:4569 total liabilities were ¥54.41B for the fiscal quarter, a -5.09% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.